B. Metzler seel. Sohn & Co. AG Raises Stake in Corteva, Inc. (NYSE:CTVA)

B. Metzler seel. Sohn & Co. AG lifted its position in shares of Corteva, Inc. (NYSE:CTVA) by 69.0% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 2,870,859 shares of the company’s stock after buying an additional 1,172,110 shares during the period. Corteva accounts for approximately 1.7% of B. Metzler seel. Sohn & Co. AG’s portfolio, making the stock its 13th largest holding. B. Metzler seel. Sohn & Co. AG owned approximately 0.42% of Corteva worth $163,181,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. Oak Thistle LLC acquired a new position in shares of Corteva during the 4th quarter valued at about $1,514,000. Van ECK Associates Corp boosted its holdings in shares of Corteva by 5.9% in the 4th quarter. Van ECK Associates Corp now owns 9,428,206 shares of the company’s stock valued at $537,031,000 after purchasing an additional 525,531 shares during the last quarter. Swedbank AB boosted its holdings in Corteva by 51.9% in the fourth quarter. Swedbank AB now owns 695,641 shares of the company’s stock valued at $39,624,000 after acquiring an additional 237,764 shares during the last quarter. Assenagon Asset Management S.A. increased its stake in Corteva by 755.8% during the fourth quarter. Assenagon Asset Management S.A. now owns 552,769 shares of the company’s stock worth $31,486,000 after acquiring an additional 488,181 shares during the last quarter. Finally, S.E.E.D. Planning Group LLC lifted its stake in shares of Corteva by 54.5% in the 4th quarter. S.E.E.D. Planning Group LLC now owns 96,103 shares of the company’s stock valued at $5,474,000 after purchasing an additional 33,886 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Price Performance

CTVA opened at $61.08 on Monday. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.93 and a current ratio of 1.45. Corteva, Inc. has a 1-year low of $50.01 and a 1-year high of $66.24. The company has a 50-day moving average of $62.53 and a 200-day moving average of $60.13. The company has a market capitalization of $41.72 billion, a P/E ratio of 47.35, a PEG ratio of 1.68 and a beta of 0.79.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. Equities analysts expect that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were given a $0.17 dividend. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.11%. Corteva’s payout ratio is currently 52.71%.

Analyst Upgrades and Downgrades

Several research analysts recently commented on CTVA shares. Oppenheimer raised their price target on shares of Corteva from $70.00 to $72.00 and gave the company an “outperform” rating in a report on Friday, February 7th. UBS Group reduced their target price on shares of Corteva from $74.00 to $73.00 and set a “buy” rating on the stock in a report on Friday, January 10th. Bank of America increased their price target on Corteva from $69.00 to $73.00 and gave the company a “buy” rating in a report on Tuesday, February 11th. Royal Bank of Canada boosted their price objective on Corteva from $72.00 to $73.00 and gave the stock an “outperform” rating in a research note on Friday, February 7th. Finally, Citigroup increased their target price on Corteva from $69.00 to $74.00 and gave the company a “buy” rating in a research note on Wednesday, January 29th. One analyst has rated the stock with a sell rating, four have given a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, Corteva presently has an average rating of “Moderate Buy” and an average target price of $68.00.

Insider Activity

In related news, insider Brian Titus sold 26,560 shares of the firm’s stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $63.74, for a total value of $1,692,934.40. Following the sale, the insider now owns 11,347 shares of the company’s stock, valued at approximately $723,257.78. This trade represents a 70.07 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.14% of the company’s stock.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.